LH846
LH846 is a selective inhibitor of CKIδ, with an IC50 of 290 nM, and less potently inhibits CKIα and CKIε, with IC50s of 2.5 μM and 1.3 μM, respectively.
Product Specifications
CAS Number
[639052-78-1]
UNSPSC
12352005
Hazard Statement
H302, H413
Target
Casein Kinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/LH846.html
Purity
98.89
Solubility
DMSO : ≥ 33.33 mg/mL
Smiles
O=C(NC1=NC2=CC(Cl)=C(C)C=C2S1)CC3=CC=CC=C3
Molecular Formula
C16H13ClN2OS
Molecular Weight
316.81
Precautions
H302, H413
References & Citations
[1]Lee JW, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50 (45) :10608-11.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CK1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
219440 50 µg
BACE-1, Recombinant, Human, Active (beta-Secretase 1, Beta-Secretase) discontinued
Ask
View Details 
abx495169-02 5x 96 Tests
Human Serine/threonine-Protein Kinase B-Raf (BRAF) CLIA Kit
Ask
View Details